These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 20473253

  • 21. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP.
    Ueno T, Ikeda T, Ikeda K, Taniuchi H, Suda S, Yeung MY, Matsuno N.
    J Surg Res; 2011 Nov; 171(1):183-90. PubMed ID: 20338589
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome.
    Tsushima K, Kubo K, Yoshikawa S, Koizumi T, Yasuo M, Furuya S, Hora K.
    Ther Apher Dial; 2007 Apr; 11(2):138-45. PubMed ID: 17381535
    [Abstract] [Full Text] [Related]

  • 24. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C, Hara Y, Kuriyama N, Nakamura T, Nishida O.
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hemoperfusion with an immobilized polymyxin B fiber column decreases macrophage and monocyte activity.
    Kushi H, Miki T, Sakagami Y, Sato J, Saito T, Tanjoh K.
    Ther Apher Dial; 2009 Dec; 13(6):515-9. PubMed ID: 19954475
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Relationship between treatment resistance to hemoperfusion using a polymyxin B-immobilized fiber column and oxidative stress.
    Sakamoto Y, Mashiko K, Obata T, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y.
    ASAIO J; 2008 Dec; 54(4):412-5. PubMed ID: 18645360
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T, Sugaya T, Koide H.
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [Abstract] [Full Text] [Related]

  • 31. Hemoperfusion with a polymyxin B fiber column decreases clotting activity.
    Kushi H, Miki T, Sakagami Y, Sato J, Saito T, Tanjoh K.
    Ther Apher Dial; 2009 Dec; 13(6):528-33. PubMed ID: 19954477
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
    Ebihara I, Hirayama K, Kaneko S, Nagai M, Ogawa Y, Fujita S, Usui J, Mase K, Yamagata K, Kobayashi M.
    Ther Apher Dial; 2008 Aug; 12(4):285-91. PubMed ID: 18789115
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.